Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS
· Delayed Price · Currency is USD
0.128
-0.007 (-5.24%)
At close: Mar 9, 2026
KBLB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1.57 | 0.67 | 2.55 | 3.86 | 2.36 | 0.82 | Upgrade
|
| Short-Term Investments | - | - | - | 0.1 | - | - | Upgrade
|
| Cash & Short-Term Investments | 1.57 | 0.67 | 2.55 | 3.96 | 2.36 | 0.82 | Upgrade
|
| Cash Growth | 31.57% | -73.62% | -35.58% | 68.20% | 188.29% | 553.40% | Upgrade
|
| Inventory | 0.03 | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Prepaid Expenses | 0.05 | 0.06 | 0.01 | 0.02 | 0.01 | 0 | Upgrade
|
| Total Current Assets | 1.64 | 0.74 | 2.57 | 3.98 | 2.37 | 0.82 | Upgrade
|
| Property, Plant & Equipment | 0.22 | 0.13 | 0.16 | 0.15 | 0.22 | 0.45 | Upgrade
|
| Long-Term Investments | 0.49 | 0.63 | 0.49 | 0.44 | 0.44 | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 2.36 | 1.51 | 3.23 | 4.57 | 3.02 | 1.28 | Upgrade
|
| Accounts Payable | 0.79 | 0.8 | 0.93 | 0.9 | 0.59 | 3.43 | Upgrade
|
| Accrued Expenses | 7.77 | 7.15 | 6.26 | 5.42 | 4.96 | 1.71 | Upgrade
|
| Short-Term Debt | 1.57 | 1.62 | 1.65 | 1.71 | 2.16 | 1.8 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.06 | 0.06 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | 0.12 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.35 | 0.33 | Upgrade
|
| Total Current Liabilities | 10.18 | 9.61 | 8.89 | 8.07 | 8.16 | 7.45 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.1 | 0.15 | Upgrade
|
| Long-Term Leases | 0.13 | 0.04 | 0.05 | 0.02 | 0.06 | 0.25 | Upgrade
|
| Total Liabilities | 10.31 | 9.65 | 8.94 | 8.09 | 8.32 | 7.85 | Upgrade
|
| Common Stock | 30.36 | 27.39 | 27.39 | 27.08 | 22.39 | 17.12 | Upgrade
|
| Additional Paid-In Capital | 12.34 | 12.29 | 11.35 | 10.83 | 9.89 | 5.83 | Upgrade
|
| Retained Earnings | -55.92 | -53.09 | -49.69 | -46.66 | -42.81 | -34.77 | Upgrade
|
| Comprehensive Income & Other | 0.02 | 0.02 | 0.02 | - | 0.02 | 0.02 | Upgrade
|
| Total Common Equity | -13.19 | -13.39 | -10.92 | -8.74 | -10.51 | -11.79 | Upgrade
|
| Shareholders' Equity | -7.96 | -8.15 | -5.71 | -3.52 | -5.3 | -6.57 | Upgrade
|
| Total Liabilities & Equity | 2.36 | 1.51 | 3.23 | 4.57 | 3.02 | 1.28 | Upgrade
|
| Total Debt | 1.75 | 1.7 | 1.75 | 1.77 | 2.42 | 2.38 | Upgrade
|
| Net Cash (Debt) | -0.19 | -1.03 | 0.8 | 2.19 | -0.07 | -1.57 | Upgrade
|
| Net Cash Growth | - | - | -63.30% | - | - | - | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 1,081 | 1,043 | 1,038 | 1,033 | 950.91 | 854.41 | Upgrade
|
| Total Common Shares Outstanding | 1,076 | 1,038 | 1,038 | 1,031 | 927.38 | 854.41 | Upgrade
|
| Working Capital | -8.54 | -8.87 | -6.31 | -4.09 | -5.8 | -6.63 | Upgrade
|
| Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Tangible Book Value | -13.19 | -13.39 | -10.92 | -8.74 | -10.51 | -11.79 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Machinery | 0.19 | 0.18 | 0.18 | 0.17 | 0.17 | 0.15 | Upgrade
|
| Leasehold Improvements | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.